Status:
COMPLETED
Creatinine Clearance as a Predictor of Successful Withdrawl of Continuous Renal Replacement Therapy in Intensive Care
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Dialysis Withdrawal
Creatinine Clearance
Eligibility:
All Genders
18+ years
Brief Summary
Acute renal failure is a common complication in patients admitted to intensive care. Due to the increasing incidence of acute renal failure, the use of Continuous Renal Replacement Therapy (CRRT) is o...
Eligibility Criteria
Inclusion
- Dialysis for AKI with minimum 12 hours of continuous renal replacement therapy (CVVH-CVVHD)
- Patient in whom dialysis withdrawal is being considered
- Patients over 18 years of age
Exclusion
- Pre-existing chronic end-stage renal failure on chronic dialysis
- Extrarenal purification during hospitalization prior to admission to intensive care unit
- Inability to assess the primary outcome
- Kidney Transplantation
- Pregnant Women
- Person not affiliated to a national health insurance
- Decision to limit or stop therapy
- Isolated hyperkalemia
- Refusal of patient participation
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04375358
Start Date
October 1 2018
End Date
March 30 2021
Last Update
June 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourgogne
Dijon, France, 21000